Chargement en cours...
Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency
Tafazzin is the mitochondrial enzyme that catalyzes transacylation between a phospholipid and a lysophospholipid in remodeling. Mutations in tafazzin cause Barth syndrome, a potentially life-threatening disease with the major symptom of cardiomyopathy. In the tafazzin-deficient heart, cardiolipin (C...
Enregistré dans:
| Publié dans: | Biochemistry |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893435/ https://ncbi.nlm.nih.gov/pubmed/29557170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biochem.8b00042 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|